Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

The University of Paris Selects ACD/Percepta Software to Enhance Teaching and Research into Pharmaceuticals

Published: Monday, December 16, 2013
Last Updated: Monday, December 16, 2013
Bookmark and Share
ADME/Tox and PhysChem predictions on the Percepta Platform will help educate and train the next generation of pharmaceutical scientists.

The Université Paris-Sud, School of Pharmacy, has selected ACD/Labs’ ADME, Toxicity, and PhysChem predictors on the ACD/Percepta Platform, to enable in silico evaluation of pharmaceutical substances and research compounds.

The software is to be applied by undergraduate students to help them understand the effect of drugs on the body in terms of toxicity, and the body’s ability to use and dispose of a drug, i.e., ADME properties (absorption, distribution, metabolism, and excretion). Graduate students will use the software in their investigations towards innovative therapeutics from natural products. 

“As an educator I want to prepare my students for a successful career in the pharmaceutical industry. Software is used more and more, and our students will benefit from being exposed to these tools early in their education”, says Prof. Delphine Joseph. “Ease of use was very important to us, particularly since undergraduate classes will only use the software for one academic session, to understand the concepts behind drug design. Our research programs will benefit because graduate students will be able to profile synthetic modifications to molecular structures in silico, and investigate the effect on physiological behavior.”

Percepta modules provide predictions for oral bioavailability, CYP450 inhibition, blood brain barrier permeation, hERG inhibition, lipophilicity, and many other physiologically relevant properties. The values and supporting information provided in the software (such as similar structures, effect of pH, and color coded mapping) can help scientists understand the behavior of molecular structures, and direct discovery research in terms of achieving an optimal drug-like profile.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.
Identified Compound Stops Cells Making Ribosomes
From study in yeast, researchers have identifed a compound that interferes with the assembly of ribosomes.
CES Score May Predict Response to Cancer Treatment
Researchers identify new type of biomarker that helps predict prognosis and response to several types of cancer treatment.
Treating Sepsis with Marine Mitochondria
Mitochondrial alternative oxidase from a marine animal combats bacterial sepsis.
New Therapeutic Target for Crohn’s Disease
A promising new target for drugs that treat IBD has been identified along with a possible biomarker for IBD severity.
Analysing 10,000 Cells Simultaneously
New techniquethat traps 10,000 cells on a single chip has potential for cancer screening for individuals.
Researchers Find Fungus-Fighting Compound
A compound has been identifed that blocks growth of a fungus responsible for lung infections and allergic reactions.
Peer Reviewed Study Demonstrates Mass Spec Technique
The peer reviewed study demonstrates MS workflow, TMTCalibrator workflow, which dramatically enhances detection of key early stage Alzheimer’s biomarkers.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!